学术急诊医学档案

Johnson BI. Paradoxical embolism. Journal of clinical pathology. 1951;4(3):316-32.

Hara H. Patent foramen ovale [updated Jan 25, 2018.].

Rigatelli G, Rigatelli A. Closing patent foramen ovale in cryptogenic stroke: The underscored importance of other interatrial shunt variants. World journal of cardiology. 2015;7(6):326.

d'Audiffret A, Shenoy S, Ricotta J, Dryjski M. The role of thrombolytic therapy in the management of paradoxical embolism. Cardiovascular Surgery. 1998;6(3):302-6.

Konstantinides S, Geibel A, Kasper W, Olschewski M, Blümel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97(19):1946-51.

Seiler C. Patent foramen ovale (PFO): is there life before death in the presence of PFO? European journal of clinical investigation. 2015;45(8):875-82.

Goldhaber SZ. Unsolved issues in the treatment of pulmonary embolism. Thrombosis research. 2001;103(6):V245-V55.

Zanchetta M, Rigatelli G, Pedon L, Zennaro M, Carrozza A, Onorato E. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single amplatzer device: feasibility of a new method. The Journal of invasive cardiology. 2005;17(5):262-5.

Caretta G, Robba D, Bonadei I, Teli M, Fontanella B, Vizzardi E, et al. Multiorgan paradoxical embolism consequent to acute pulmonary thromboembolism with patent foramen ovale: a case report. Cases Journal. 2009;2(1):8358.

Chant H, McCollum C. Stroke in young adults: the role of paradoxical embolism. Thrombosis and haemostasis. 2001;85(01):22-9.

Chartier L, Béra J, Delomez M, Asseman P, Beregi J-P, Bauchart J-J, et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation. 1999;99(21):2779-83.

Pishgahi M, Alirezaei T, Hajimoradi B, Nekooghadam SM, Shahi S. Systemic fibrinolytic therapy in the presence of absolute contraindication; a case series. Emergency. 2018;6(1):25.